Vitoc Vlad's Form 4/A amendment
AmendedMAIA Biotechnology, Inc. (MAIA) · filed Dec 4, 2025
- Accession no.
- 0001878313-25-000060
- Filed
- Dec 4, 2025
- Trade date
- Nov 25, 2025
- Filing delay
- 9 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 28, 2025
This filing lists 1 non-derivative transaction. Open-market purchases total $10.2K. It was filed 9 days after the trade.
This amendment replaces 0001878313-25-000047 (filed Nov 28, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vitoc VladCIK 0001913257 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | PPurchaseAcquired | +10,500 | $0.97 | +$10,185 | 831,421 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The original Form 4 filed November 28, 2025 had the incorrect total share balance owned by Mr. Vitoc's spouse. This Amended Form 4 is now reflecting the correct share balance owned.
- F2
These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.